MET and non-small cell lung carcinoma: In cancer cell lines displaying MET overexpression, the shRNA-targeted inhibition of MET signaling significantly impaired cell viability [112,113]; in NSCLC cell lines specifically, the inhibition of MET in METamp lines led to growth inhibition characterized by a block in the cell cycle at the G1-S transition [114].